Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

HLA-DR polymorphism influences T-cell precursor frequencies to Epstein-Barr virus (EBV) gp110: implications for the association of HLA-DR antigens with rheumatoid arthritis.

Toussirot E, Auger I, Roudier C, Luka J, Wendling D, Tiberghien P, Roudier J.

Tissue Antigens. 1999 Aug;54(2):146-52.

PMID:
10488741
3.

Epstein-Barr virus and rheumatoid arthritis.

Balandraud N, Roudier J, Roudier C.

Autoimmun Rev. 2004 Jul;3(5):362-7. Review.

PMID:
15288002
4.

Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.

Auger I, Sebbag M, Vincent C, Balandraud N, Guis S, Nogueira L, Svensson B, Cantagrel A, Serre G, Roudier J.

Arthritis Rheum. 2005 Nov;52(11):3424-32.

5.

A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DR-restricted CD4(+) T lymphocytes.

Rajnavölgyi E, Nagy N, Thuresson B, Dosztányi Z, Simon A, Simon I, Karr RW, Ernberg I, Klein E, Falk KI.

Int Immunol. 2000 Mar;12(3):281-93.

PMID:
10700463
6.

Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.

Klatt T, Ouyang Q, Flad T, Koetter I, Bühring HJ, Kalbacher H, Pawelec G, Müller CA.

J Rheumatol. 2005 Feb;32(2):239-51.

PMID:
15693083
7.

Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1.

Landais E, Saulquin X, Scotet E, Trautmann L, Peyrat MA, Yates JL, Kwok WW, Bonneville M, Houssaint E.

Blood. 2004 Feb 15;103(4):1408-16. Epub 2003 Oct 16.

8.

The Epstein-Barr virus glycoprotein gp110, a molecular link between HLA DR4, HLA DR1, and rheumatoid arthritis.

Roudier J, Rhodes G, Petersen J, Vaughan JH, Carson DA.

Scand J Immunol. 1988 Apr;27(4):367-71. Review. No abstract available.

PMID:
2452474
10.

Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis.

Massa M, Mazzoli F, Pignatti P, De Benedetti F, Passalia M, Viola S, Samodal R, La Cava A, Giannoni F, Ollier W, Martini A, Albani S.

Arthritis Rheum. 2002 Oct;46(10):2721-9.

11.
12.

Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF).

Barrera P, Balsa A, Alves H, Westhovens R, Maenaut K, Cornélis F, Fritz P, Bardin T, Ceu Maia M, Lopes-Vaz A, Pascual Salcedo D, de la Concha E, Radstake T, van de Putte LB, Migliorini P, Prudhomme JF, Charron D, Spyropoulou M, Mendes A, Spaepen M, Martinez M, Stavropoulos C; European Consortium on Rheumatoid Arthritis Families.

J Rheumatol. 2001 May;28(5):968-74.

PMID:
11361224
13.

Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update.

Toussirot E, Roudier J.

Joint Bone Spine. 2007 Oct;74(5):418-26. Epub 2007 Jun 8. Review.

PMID:
17625943
14.

Specific overexpression of rheumatoid arthritis-associated HLA-DR alleles and presentation of low-affinity peptides.

Kerlan-Candon S, Louis-Plence P, Wiedemann A, Combe B, Clot J, Eliaou JF, Pinet V.

Arthritis Rheum. 2001 Jun;44(6):1281-92.

15.

Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis.

Fox RI, Luppi M, Pisa P, Kang HI.

J Rheumatol Suppl. 1992 Jan;32:18-24.

PMID:
1319486
16.
18.

HLA-DRB1 alleles encoding the "shared epitope" are associated with susceptibility to developing rheumatoid arthritis whereas HLA-DRB1 alleles encoding an aspartic acid at position 70 of the beta-chain are protective in Mexican Mestizos.

Ruiz-Morales JA, Vargas-Alarcón G, Flores-Villanueva PO, Villarreal-Garza C, Hernández-Pacheco G, Yamamoto-Furusho JK, Rodríguez-Pérez JM, Pérez-Hernández N, Rull M, Cardiel MH, Granados J.

Hum Immunol. 2004 Mar;65(3):262-9.

PMID:
15041166
19.

HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.

Laivoranta-Nyman S, Möttönen T, Hermann R, Tuokko J, Luukkainen R, Hakala M, Hannonen P, Korpela M, Yli-Kerttula U, Toivanen A, Ilonen J; FIN-RACo Trial Group.

Ann Rheum Dis. 2004 Nov;63(11):1406-12.

20.

Supplemental Content

Support Center